Dyne Therapeutics Inc (DYN)
29.73
-0.26
(-0.87%)
USD |
NASDAQ |
Nov 21, 16:00
29.36
-0.37
(-1.24%)
After-Hours: 07:48
Dyne Therapeutics Shareholders Equity (Quarterly): 705.54M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 705.54M |
| June 30, 2024 | 775.19M |
| March 31, 2024 | 478.06M |
| December 31, 2023 | 91.29M |
| September 30, 2023 | 152.04M |
| June 30, 2023 | 206.88M |
| March 31, 2023 | 241.94M |
| December 31, 2022 | 252.36M |
| September 30, 2022 | 249.74M |
| June 30, 2022 | 287.06M |
| Date | Value |
|---|---|
| March 31, 2022 | 336.46M |
| December 31, 2021 | 368.20M |
| September 30, 2021 | 414.12M |
| June 30, 2021 | 452.60M |
| March 31, 2021 | 478.26M |
| December 31, 2020 | 342.37M |
| September 30, 2020 | 366.84M |
| June 30, 2020 | 132.48M |
| December 31, 2019 | 14.04M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
14.04M
Minimum
Dec 2019
775.19M
Maximum
Jun 2024
333.97M
Average
336.46M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 1.221B |
| Capricor Therapeutics Inc | 68.26M |
| Regenxbio Inc | 301.42M |
| Catalyst Pharmaceuticals Inc | 660.94M |
| Novavax Inc | -526.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 768.84M |
| Total Liabilities (Quarterly) | 63.30M |